TYRO3 and neoplasm: Inhibition of TYRO3 in sorafenib-resistant Huh-7 cells using siRNA decreased tumor cell expansion relative to cells expressing a control siRNA and treatment with a combination of sorafenib and siTYRO3 was significantly more effective than either treatment alone.